Platelets quell the inflammation of an aging brain and body: Study finds

Platelets are behind the cognitive benefits of young blood, exercise and the longevity hormone klotho

Emergex and VIC to develop infectious disease therapies in the Gulf – Pharmaceutical Technology

VIC will have the Right of First Negotiation over new candidates proposed by Emergex for the territories covered under the agreement. Image Credit: TonelloPhotography /

October 6, 2023

J&J targets generalised myasthenia gravis landscape with nipocalimab – Pharmaceutical Technology

Nipocalimab is an IgG receptor FcRn large subunit p51 antagonist designed to compete with IgG in binding to FcRn. Credits: Skorzewiak/Shutterstock.com Johnson & Johnson (J&J)

August 30, 2024

Fruit and menthol e-cigarette flavors drive use among teens, Indonesian study finds

The associations between sensation-seeking behavior and electronic cigarette (e-cigarette) use.

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.